{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:27Z","timestamp":1790746707296,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171560"],"award-info":[{"award-number":["81171560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the \u2018Par-Eu Scholars Program\u2019 of Chongqing City, the National Science and Technology Major Project of China","award":["2012ZX10002007001"],"award-info":[{"award-number":["2012ZX10002007001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fatty acid synthase (FASN) is highly expressed in various types of cancer and has an important role in carcinogenesis and metastasis. To clarify the mechanisms of FASN in liver cancer invasion and metastasis, the FASN protein interaction network in liver cancer was identified by targeted proteomic analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Wound healing and Transwell assays was performed to observe the effect of FASN during migration and invasion in liver cancer. Isobaric tags for relative and absolute quantitation (iTRAQ)-based mass spectrometry were used to identify proteins interacting with FASN in HepG2 cells. Differential expressed proteins were validated by co-immunoprecipitation, western blot analyses and confocal microscopy. Western blot and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were performed to demonstrate the mechanism of FASN regulating metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>FASN knockdown inhibited migration and invasion of HepG2 and SMMC7721 cells. A total of, 79 proteins interacting with FASN were identified. Additionally, gene ontology term enrichment analysis indicated that the majority of biological regulation and cellular processes that the FASN-interacting proteins were associated with. Co-precipitation and co-localization of FASN with fascin actin-bundling protein 1 (FSCN1), signal-induced proliferation-associated 1 (SIPA1), spectrin \u03b2, non-erythrocytic 1 (SPTBN1) and CD59 were evaluated. Knockdown of FASN in liver cancer reduced the expression of FSCN1, SIPA1, SPTBN1 and CD59. Furthermore, inhibition of FASN, FSCN1 or SPTBN1 expression in liver cancer resulted in alterations of epithelial\u2013mesenchymal transition (EMT)-associated markers E-cadherin, N-cadherin, vimentin and transcription factors, Snail and Twist, at the mRNA level, and changes in matrix metallopeptidase (MMP)-2 and MMP-9 protein expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results suggested that the FASN-interacting protein network produced by iTRAQ-based proteomic analyses may be involved in regulating invasion and metastasis in liver cancer by influencing EMT and the function of MMPs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12935-020-01409-2","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T08:04:09Z","timestamp":1595318649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis"],"prefix":"10.1186","volume":"20","author":[{"given":"Juan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-6880","authenticated-orcid":false,"given":"Huaidong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"10","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/cncr.32789","volume":"126","author":"Z Liu","year":"2020","unstructured":"Liu Z, Suo C, Mao X, et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990\u20132017. Cancer. 2020;126(10):2267\u201378.","journal-title":"Cancer"},{"issue":"2","key":"1409_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3892\/mmr.2017.6701","volume":"16","author":"X Ma","year":"2017","unstructured":"Ma X, Zhuang B, Li W. MicroRNA-296-5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion. Mol Med Rep. 2017;16(2):1565\u201372.","journal-title":"Mol Med Rep"},{"issue":"2","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1409_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1017\/S0007114520001208","volume":"124","author":"WS Yang","year":"2020","unstructured":"Yang WS, Zeng XF, Liu ZN, et al. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr. 2020;124(3):330\u201340. https:\/\/doi.org\/10.1017\/S0007114520001208.","journal-title":"Br J Nutr"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2019.10.025","volume":"469","author":"J Lv","year":"2020","unstructured":"Lv J, Zhang S, Wu H, et al. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Lett. 2020;469:22\u201334.","journal-title":"Cancer Lett"},{"issue":"8","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/jmv.25637","volume":"92","author":"NM Omran","year":"2020","unstructured":"Omran NM, El-Sherbini SM, Hegazy O, et al. Crosstalk between miR\u2010215 and epithelial\u2010mesenchymal transition specific markers (E\u2010cadherin and N\u2010cadherin) in different stages of chronic HCV infection. J Med Virol. 2020;92(8):1231\u20138. https:\/\/doi.org\/10.1002\/jmv.25637.","journal-title":"J Med Virol"},{"issue":"5","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"Xiangming Guan","year":"2015","unstructured":"Guan Xiangming. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402\u201318.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1409_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cels.2019.07.003","volume":"9","author":"Y Suhail","year":"2019","unstructured":"Suhail Y, Cain MP, Vanaja K, et al. Systems biology of cancer metastasis. Cell Syst. 2019;9(2):109\u201327.","journal-title":"Cell Syst"},{"issue":"6","key":"1409_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/molecules24061133","volume":"24","author":"P Iadarola","year":"2019","unstructured":"Iadarola P. Special issue: mass spectrometric proteomics. Molecules. 2019;24(6):1133.","journal-title":"Molecules"},{"key":"1409_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4939-8814-3_13","volume":"1871","author":"JR O\u2019Neill","year":"2019","unstructured":"O\u2019Neill JR. An overview of mass spectrometry-based methods for functional proteomics. Methods Mol Biol. 2019;1871:179\u201396.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1409_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/jpet.119.258947","volume":"371","author":"LE Lupien","year":"2019","unstructured":"Lupien LE, Dunkley EM, Maloy MJ, et al. An inhibitor of fatty acid synthase thioesterase domain with improved cytotoxicity against breast cancer cells and stability in plasma. J Pharmacol Exp Ther. 2019;371(1):171\u201385.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1409_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1940-6207.CAPR-17-0001","volume":"10","author":"KB Singh","year":"2017","unstructured":"Singh KB, Singh SV. Fatty acid synthesis intermediates represent novel noninvasive biomarkers of prostate cancer chemoprevention by phenethyl isothiocyanate. Cancer Prev Res. 2017;10(5):279\u201389.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3892\/mmr.2016.4902","volume":"13","author":"J Duan","year":"2016","unstructured":"Duan J, Sun L, Huang H, et al. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer. Mol Med Rep. 2016;13(4):3027\u201335.","journal-title":"Mol Med Rep"},{"issue":"6","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10495-017-1366-2","volume":"22","author":"S Al-Bahlani","year":"2017","unstructured":"Al-Bahlani S, Al-Lawati H, Al-Adawi M, et al. Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis. Apoptosis. 2017;22(6):865\u201376.","journal-title":"Apoptosis"},{"issue":"2","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3892\/mmr.2012.1220","volume":"7","author":"ZL Liu","year":"2013","unstructured":"Liu ZL, Mao JH, Peng AF, et al. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K\/Akt signaling pathway in vitro. Mol Med Rep. 2013;7(2):608.","journal-title":"Mol Med Rep"},{"issue":"7","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1096\/fj.201701187R","volume":"32","author":"MY Jung","year":"2018","unstructured":"Jung MY, Kang JH, Hernandez DM, et al. Fatty acid synthase is required for profibrotic TGF-\u03b2 signaling. FASEB J. 2018;32(7):3803\u201315.","journal-title":"FASEB J"},{"issue":"12","key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/labinvest.2008.97","volume":"88","author":"M Fiorentino","year":"2008","unstructured":"Fiorentino M, Zadra G, Palescandolo E, et al. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of |[beta]|-catenin in prostate cancer. Lab Invest. 2008;88(12):1340\u20138.","journal-title":"Lab Invest"},{"issue":"3","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3892\/ijo.2017.3867","volume":"50","author":"J Gong","year":"2017","unstructured":"Gong J, Shen S, Yang Y, et al. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1\u03b1\/IGFBP1 pathway. Int J Oncol. 2017;50(3):883\u201392.","journal-title":"Int J Oncol"},{"issue":"9","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","volume":"21","author":"M Arkin","year":"2014","unstructured":"Arkin M, Tang Y, Wells J. Small-molecule inhibitors of protein\u2013protein interactions: progressing toward the reality. Chem Biol. 2014;21(9):1102\u201314.","journal-title":"Chem Biol"},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-0805-9_1","volume":"1164","author":"Z Ning","year":"2014","unstructured":"Ning Z, Hawley B, Chiang CK, et al. Detecting protein\u2013protein interactions\/complex components using mass spectrometry coupled techniques. Methods Mol Biol. 2014;1164:1\u201313.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1074\/mcp.M112.023085","volume":"12","author":"D Ghosh","year":"2013","unstructured":"Ghosh D, Li Z, Tan XF, et al. iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis. Mol Cell Proteom MCP. 2013;12(7):1865\u201380.","journal-title":"Mol Cell Proteom MCP"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jep.2018.11.032","volume":"232","author":"T Liu","year":"2018","unstructured":"Liu T, Zhou J, Cui H, et al. iTRAQ-based quantitative proteomics reveals the neuroprotection of rhubarb in experimental intracerebral hemorrhage. J Ethnopharmacol. 2018;232:244\u201354. https:\/\/doi.org\/10.1016\/j.jep.2018.11.032","journal-title":"J Ethnopharmacol"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jprot.2015.12.014","volume":"133","author":"P Zhang","year":"2016","unstructured":"Zhang P, Zhu S, Li Y, et al. Quantitative proteomics analysis to identify diffuse axonal injury biomarkers in rats using iTRAQ coupled LC\u2013MS\/MS. J Proteom. 2016;133:93\u20139.","journal-title":"J Proteom"},{"issue":"4","key":"1409_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"1409_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs010","volume-title":"Associations between obesity and cancer the role of fatty acid synthase","author":"D Wang","year":"2012","unstructured":"Wang D, DuBois RN. Associations between obesity and cancer the role of fatty acid synthase. Oxford: Oxford University Press; 2012."},{"issue":"12","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/17460441.2016.1245286","volume":"11","author":"TS Angeles","year":"2016","unstructured":"Angeles TS, Hudkins RL. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors. Expert Opin Drug Discov. 2016;11(12):1187\u201399.","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"1709389","DOI":"10.1080\/23723556.2019.1709389","volume":"7","author":"MJ Bueno","year":"2020","unstructured":"Bueno MJ, Quintela-Fandino M. Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention. Mol Cell Oncol. 2020;7(2):1709389.","journal-title":"Mol Cell Oncol"},{"key":"1409_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2017.02.021","volume":"177","author":"D Buckley","year":"2017","unstructured":"Buckley D, Duke G, Heuer TS, et al. Fatty acid synthase\u2014modern tumor cell biology insights into a classical oncology target. Pharmacol Ther. 2017;177:23\u201331.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1128\/JVI.02526-12","volume":"87","author":"JT Huang","year":"2013","unstructured":"Huang JT, Tseng CP, Liao MH, et al. Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. J Virol. 2013;87(9):4994\u20135004.","journal-title":"J Virol"},{"issue":"29","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"46321","DOI":"10.18632\/oncotarget.10113","volume":"7","author":"T Karantanos","year":"2016","unstructured":"Karantanos T, Karanika S, Wang J, et al. Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget. 2016;7(29):46321\u201334.","journal-title":"Oncotarget"},{"issue":"2","key":"1409_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3892\/or.2016.4889","volume":"36","author":"N Zhang","year":"2016","unstructured":"Zhang N, Bi X, Zeng Y, et al. TGF-\u03b21 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression. Oncol Rep. 2016;36(2):977\u201383.","journal-title":"Oncol Rep"},{"issue":"3","key":"1409_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/ijo.2013.2232","volume":"44","author":"SH Park","year":"2014","unstructured":"Park SH, Song JY, Kim YK, et al. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells. Int J Oncol. 2014;44(3):637.","journal-title":"Int J Oncol"},{"issue":"1","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-014-0099-0","volume":"33","author":"L Guo","year":"2014","unstructured":"Guo L, Bai H, Zou D, et al. The role of microRNA-133b and its target gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 2014;33(1):99.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1002\/jcp.26264","volume":"233","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhao Z, Duan X, et al. FSCN1 predicts survival and is regulated by a PI3K-dependent mechanism in renal cell carcinoma. J Cell Physiol. 2018;233(6):4748\u201358.","journal-title":"J Cell Physiol"},{"key":"1409_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.mce.2015.10.021","volume":"419","author":"C Liu","year":"2015","unstructured":"Liu C, Gao H, Cao L, et al. The role of FSCN1 in migration and invasion of pituitary adenomas. Mol Cell Endocrinol. 2015;419:217.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1409_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/bjc.2013.676","volume":"110","author":"N Akanuma","year":"2014","unstructured":"Akanuma N, Hoshino I, Akutsu Y, et al. MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer. 2014;110(1):189\u201398.","journal-title":"Br J Cancer"},{"issue":"5","key":"1409_CR37","first-page":"321","volume":"9","author":"K Ji","year":"2012","unstructured":"Ji K, Ye L, Toms AM, et al. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics Proteomics. 2012;9(5):321\u20137.","journal-title":"Cancer Genomics Proteomics"},{"issue":"11","key":"1409_CR38","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/onc.2014.36","volume":"34","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Gong Y, Hu D, et al. Nuclear SIPA1 activates integrin \u03b21 promoter and promotes invasion of breast cancer cells. Oncogene. 2015;34(11):1451\u201362.","journal-title":"Oncogene"},{"issue":"2","key":"1409_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.yexcr.2017.02.026","volume":"352","author":"T Takahara","year":"2017","unstructured":"Takahara T, Kasamatsu A, Yamatoji M, et al. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7. Exp Cell Res. 2017;352(2):357\u201363.","journal-title":"Exp Cell Res"},{"issue":"23","key":"1409_CR40","doi-asserted-by":"publisher","first-page":"33557","DOI":"10.18632\/oncotarget.9677","volume":"7","author":"N Horikoshi","year":"2016","unstructured":"Horikoshi N, Pandita RK, Mujoo K, et al. \u03b22-spectrin depletion impairs DNA damage repair. Oncotarget. 2016;7(23):33557\u201370.","journal-title":"Oncotarget"},{"issue":"7","key":"1409_CR41","first-page":"1191","volume":"19","author":"SY Wang","year":"2015","unstructured":"Wang SY, Feng LY, Meng ZQ. Bicluster and pathway enrichment analysis related to tumor progression of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2015;19(7):1191\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1409_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.7150\/ijbs.13420","volume":"12","author":"HJ Baek","year":"2016","unstructured":"Baek HJ, Lee YM, Kim TH, et al. Caspase-3\/7-mediated cleavage of \u03b22-spectrin is required for acetaminophen-induced liver damage. Int J Biol Sci. 2016;12(2):172.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"1409_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1245\/s10434-013-3460-1","volume":"21","author":"S Kiriyama","year":"2014","unstructured":"Kiriyama S, Yokoyama S, Ueno M, et al. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma. Ann Surg Oncol. 2014;21(4):505\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1409_CR44","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/hep.27558","volume":"61","author":"X Zhi","year":"2015","unstructured":"Zhi X, Lin L, Yang S, et al. \u03b2II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology. 2015;61(2):598\u2013612.","journal-title":"Hepatology"},{"issue":"8","key":"1409_CR45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2217\/fon-2017-0498","volume":"14","author":"R Zhang","year":"2018","unstructured":"Zhang R, Liu Q, Liao Q, et al. CD59: a promising target for tumor immunotherapy. Future Oncol. 2018;14(8):781\u201391.","journal-title":"Future Oncol"},{"issue":"5","key":"1409_CR46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3892\/ijo.2016.3408","volume":"48","author":"Q Ouyang","year":"2016","unstructured":"Ouyang Q, Zhang L, Jiang Y, et al. The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer. Int J Oncol. 2016;48(5):2015\u201324.","journal-title":"Int J Oncol"},{"issue":"7","key":"1409_CR47","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5858\/arpa.2013-0064-OA","volume":"138","author":"Y Shang","year":"2014","unstructured":"Shang Y, Chai N, Gu Y, et al. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138(7):910\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"1409_CR48","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/onc.2015.258","volume":"35","author":"MT Goswami","year":"2016","unstructured":"Goswami MT, Kumar RA, Himabindu K, et al. Regulation of complement dependent cytotoxicity by TGF-\u03b2-induced epithelial\u2013mesenchymal transition. Oncogene. 2016;35(15):1888\u201398.","journal-title":"Oncogene"},{"issue":"3","key":"1409_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5582\/bst.2018.01082","volume":"12","author":"F Qi","year":"2018","unstructured":"Qi F, Wang J, Zhao L, et al. Cinobufacini inhibits epithelial\u2013mesenchymal transition of human hepatocellular carcinoma cells through c-Met\/ERK signaling pathway. Biosci Trends. 2018;12(3):291\u20137.","journal-title":"Biosci Trends"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01409-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-020-01409-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01409-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:25:54Z","timestamp":1626823554000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-020-01409-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1186\/s12935-020-01409-2","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"13 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}